Day: July 3, 2024

Blender Bites New Superberry Sport™ 1-Step Smoothie Launches at 151 Locations at Large Wholesale Club Chain in the USA

VANCOUVER, British Columbia, July 03, 2024 (GLOBE NEWSWIRE) — Blender Bites Limited (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL4, WKN: A3DMEJ), a multi award-winning Canadian company involved in the development and marketing of a line of premium, organic and plant-based pre-portioned frozen functional foods, is excited to announce that its Superberry Sport™ powered by Orgain and Liquid Sunshine™ 1-Step Smoothies are now on shelves in 151 locations in one of the leading operators of membership warehouse clubs (the “Wholesale Club Chain” or “Chain”) in the United States. This expansion into the Wholesale Club Chain spans 16 states, marking significant progress in Blender Bites’ growth and accessibility in the United States. In addition, Blender Bites’ new flavor Superberry Sport™...

Continue reading

Texas Roadhouse, Inc. to Announce Second Quarter Earnings on July 25, 2024

LOUISVILLE, Ky., July 03, 2024 (GLOBE NEWSWIRE) — Texas Roadhouse, Inc. (NasdaqGS: TXRH) announced today that it will release second quarter 2024 financial results on Thursday, July 25, 2024 after the market close. A conference call will follow at 5:00 PM ET and will be webcast live from the investor relations portion of the Company’s website at www.texasroadhouse.com. Listeners may also access the call by dialing (888) 440-5667 or (646) 960-0476 for international calls and referencing the Texas Roadhouse, Inc. Second Quarter 2024 Earnings. A replay of the call will be available until August 1, 2024 by dialing (800) 770-2030 or (609) 800-9909 for international calls and using conference ID 7714420. About the Company Texas Roadhouse is a growing restaurant company operating predominantly in the casual dining segment that first...

Continue reading

Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium

Multiple studies confirm ART12.11’s superior advantages as a product candidate for the treatment of anxiety related disorders SOLANA BEACH, Calif., July 03, 2024 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological conditions, today announced several presentations about ART12.11, Artelo’s proprietary cocrystal combination drug candidate, were delivered at the 34th Annual International Cannabinoid Research Society (ICRS) Symposium held June 30 through July 5, 2024 in Salamanca, Spain. Andrew Yates, Ph.D., Chief Scientific Officer at Artelo, presented results from two studies entitled, “ART12.11, a Novel Cannabidiol: Tetramethylpyrazine Cocrystal, Demonstrates...

Continue reading

HomeTrust Bank Named a 2024 Best Place to Work in South Carolina

ASHEVILLE, N.C., July 03, 2024 (GLOBE NEWSWIRE) — HomeTrust Bancshares, Inc. (NASDAQ: HTBI) (“Company”), the holding company of HomeTrust Bank (“Bank”, “HomeTrust” or “HTB”), today announced that the Bank has been named a 2024 Best Place to Work in South Carolina by Best Companies Group. “We are very proud of this recognition in South Carolina,” said C. Hunter Westbrook, President & Chief Executive Officer. “HomeTrust has always had the goal of being a high performing regional community bank, and we believe the most important strategic initiative to achieve this goal was to create a recognized best place to work with a culture that created a sense of belonging. Happy, engaged teammates serve customers better and drive higher results.” To receive this recognition, companies across South Carolina completed a two-part survey...

Continue reading

Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment

Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses preliminary positive results from the first five “lead-in” patients in the Company’s ongoing human clinical trial THE WOODLANDS, TX , July 03, 2024 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it recently participated in a Virtual Investor “What This Means” segment. For the segment, Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discussed the current standard of care for people with pancreatic cancer pain and how Autonomix is working to significantly advance pain management and allow for more effective intervention with fewer side effects...

Continue reading

Blackford Capital Acquires Industrial Molding Corporation from NN, Inc.

The first add-on acquisition for Blackford portfolio company Davalor Mold Company, IMC delivers a significant expansion in industrial precision injection molded product capabilities Industrial Molding Corporation (“IMC”) Facilities Industrial Molding Corporation (“IMC”) Facilities Industrial Molding Corporation (“IMC”) Injection Molding Machine Industrial Molding Corporation (“IMC”) Injection Molding Machine GRAND RAPIDS, Mich., July 03, 2024 (GLOBE NEWSWIRE) — Blackford Capital (“Blackford”), a leading lower middle market private equity firm, announced today the acquisition of Industrial Molding Corporation (“IMC”), an injection molded plastic products manufacturer and subsidiary of NN, Inc. (NASDAQ: NNBR), as the first add-on acquisition for its portfolio company, Davalor Mold Company, LLC (“Davalor”). IMC is an...

Continue reading

Turmalina Metals Corp. to Acquire the Colquemayo Copper-Gold-Silver Epithermal-Porphyry Project in Peru with Reported Drill Assays Including 237.3 m of 2.4% Copper

VANCOUVER, British Columbia, July 03, 2024 (GLOBE NEWSWIRE) — Turmalina Metals Corp. (“Turmalina”, or the “Company”; TBX-TSXV, TBXXF-OTCQX, 3RI-FSE) is pleased to announce that it has entered into a Mineral Property Option Agreement (the “Option Agreement”) with Compania De Minas Buenaventura S.A.A. (the “Optionor”) and Aurora Copper Peru, a wholly-owned subsidiary of the Company (“Turmalina SubCo”), whereby the Optionor has granted Turmalina SubCo the option (the “Option”) to acquire 100% of the Optionor’s title and interest in nine (9) mining concessions located in Peru (the “Colquemayo Project”). The Optionor is at arm’s length from the Company and Turmalina SubCo. Highlights Option to acquire 100% of the advanced brownfields Colquemayo Project. Colquemayo is an epithermal and porphyry Cu-Ag-Au exploration project located in...

Continue reading

Top Electrical Distributor Chooses Bridgeline’s AI-Powered HawkSearch

WOBURN, Mass., July 03, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a global leader in AI-powered marketing technology, today announced that one of the top 10 leading electrical distributors in the United States has chosen Bridgeline’s HawkSearch to handle their sophisticated search needs across hundreds of local store websites. HawkSearch’s merchandising capabilities will increase sales across nearly one thousand local store websites by improving navigation within the distributor’s catalog of five million products. Through HawkSearch’s new Multi-Engine Management (MEM) feature, the distributor can easily make corporate changes to hundreds of local store websites. Additionally, HawkSearch enables each store to implement targeted local campaigns. The MEM feature provides scale and control for the corporate...

Continue reading

Gulf Resources Announces the Signing of Agreements to Acquire Crude Salt Fields

SHOUGUANG, China, July 03, 2024 (GLOBE NEWSWIRE) — Gulf Resources, Inc. (Nasdaq: GURE) (“Gulf Resources”, “we,” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that its wholly owned subsidiary, Shouguang Hengde Salt Industry Co. Ltd (“SHSI”), entered into a series of agreements to acquire crude salt fields for an aggregate price of RMB280,762,000 (approximately US$38,619,257 based on the current exchange rate on July 3, 2024). The purchase includes 5 parcels of crude salt fields with a total size of 5,141,000 square meters (approximately 1,270 acres). 80% of the transfer or RMB224,609,600.00 (approximately USD $30,895,406) will be paid in cash upon signing of the agreements. The remaining 20% will be paid in shares of common stock of the Company within three...

Continue reading

SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device

DENVER, July 03, 2024 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has agreed to the final labeling for SeaStar Medical’s QUELIMMUNE™, the Selective Cytopheretic Device for pediatric patients, paving the way under the Humanitarian Use Device (HUD) designation to market the therapeutic device in the U.S. for the treatment of children weighing 10 kilograms or more with acute kidney injury (AKI) and sepsis or septic condition requiring kidney replacement therapy (KRT). “We thank the FDA for diligently working through QUELIMMUNE’s labeling. We are now...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.